Antidepressant Overdose-induced Seizures

Neurologic Clinics

Volumn 29, Issue 3, 2011, Pages 565-580

  Judge, Bryan S ^a,b,c   Rentmeester, Landen L ^a,b  

^a Emergency Medicine Grand Rapids Medical Education And Research Center   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

^c SPECTRUM HEALTH   (United States)

Author keywords

Antidepressants; Deliberate self poisoning; Overdose; Seizures

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; IMIPRAMINE; ISOCARBOXAZID; MAPROTILINE; MIRTAZAPINE; MOCLOBEMIDE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; REBOXETINE; SELEGILINE; SERTRALINE; TRAMADOL; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; UNINDEXED DRUG; VENLAFAXINE;

AGITATION; DEPRESSION; DOSE RESPONSE; DRUG EXPOSURE; DRUG MEGADOSE; DRUG OVERDOSE; EPILEPTIC STATE; HEALTH CARE PERSONNEL; HEART ARRHYTHMIA; HOSPITAL PATIENT; HUMAN; HYPONATREMIA; INGESTION; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; RISK ASSESSMENT; SEIZURE; SIDE EFFECT; TREMOR; UNITED STATES;

ANTIDEPRESSIVE AGENTS; HUMANS; OVERDOSE; SEIZURES;

EID: 79960754500     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2011.05.003     Document Type: Review

References (86)

1. Olfson M., Marcus S.C. National patterns in antidepressant medication treatment. Arch Gen Psychiatry 2009, 66:848-856.
2. Bronstein A.C., Spyker D.A., Cantilena L.R., et al. 2009 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report. Clin Toxicol 2010, 48:979-1178.
3. Beuhler M.C., Spiller H.A., Sasser H.C. The outcome of unintentional pediatric bupropion ingestions: a NPDS database review. J Med Toxicol 2010, 6:4-8.
4. Pisani F., Oteri G., Costa C., et al. Effects of psychotropic drugs on seizure threshold. Drug Saf 2002, 25:91-110.
5. Thundiyil J.G., Kearney T.E., Olson K.R. Evolving epidemiology of drug-induced seizures reported to a poison control center system. J Med Toxicol 2007, 3:15-19.
6. Wills B., Erickson T. Chemically induced seizures. Clin Lab Med 2006, 26:185-209.
7. 1 binding sites. Eur J Pharmacol 1989, 164:399-401.
8. Malatynska E., Knapp R.J., Ikeda M., et al. Antidepressants and seizure-interactions at the GABA-receptor chloride-ionophore complex. Life Sci 1988, 43:303-307.
9. Yokoyama H., Iinuma K. Histamine and seizures: implications for the treatment of epilepsy. CNS Drugs 1996, 5:321-330.
10. Tuovinen K. Organophosphate-induced convulsions and prevention of neuropathological damages. Toxicology 2004, 196:31-39.
11. Teitelbaum J.S., Zatorre R.J., Carpenter S., et al. Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N Engl J Med 1990, 322:1781-1787.
12. DeToledo J.C. Lidocaine and seizures. Ther Drug Monit 2000, 22:320-322.
13. Jobe P.C., Browning R.A. The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant. Epilepsy Behav 2005, 7:602-619.
14. Dailey J.W., Naritoku D.K. Antidepressants and seizures: clinical anecdotes overshadow neuroscience. Biochem Pharmacol 1996, 52:1323-1329.
15. Krishnan K.R. Revisiting monoamine oxidase inhibitors. J Clin Psychiatry 2007, 68(Suppl 8):35-41.
16. Bonnet U. Moclobemide: evolution, pharmacodynamic, and pharmacokinetic properties. CNS Drug Rev 2002, 8:283-308.
17. Richelson E. Pharmacology of antidepressants. Mayo Clin Proc 2001, 76:511-527.
18. Frieling H., Bleich S. Tranylcypromine: new perspectives on an "old" drug. Eur Arch Psychiatry Clin Neurosci 2006, 256:268-273.
19. Bonnet U. Moclobemide: therapeutic use and clinical studies. CNS Drug Rev 2003, 9:97-140.
20. Judge B.S. Differentiating the causes of metabolic acidosis in the poisoned patient. Clin Lab Med 2006, 26:31-48.
21. 35S-t-butylbicyclophosphorothionate binding sites in rat brain. Brain Res 1988, 441:15-22.
22. Shioda K., Nisijima K., Yoshino T., et al. Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:633-640.
23. Frommer D.A., Kulig K.W., Marx J.A., et al. Tricyclic antidepressant overdose. JAMA 1987, 257:521-526.
24. Rudorfer M.V., Manji H.K., Potter W.Z. Comparative tolerability profiles of the newer versus older antidepressants. Drug Saf 1994, 10:18-46.
25. Litovitz T.L., Troutman W.G. Amoxapine overdose: seizures and fatalities. JAMA 1983, 250:1069-1071.
26. Kumlien E., Lundberg P.O. Seizure risk associated with neuroactive drugs: Data from the WHO adverse drug reactions database. Seizure 2010, 19:69-73.
27. Skowron D.M., Stimmel G.L. Antidepressants and the risk of seizures. Pharmacotherapy 1992, 12:18-22.
28. Jabbari B., Bryan G.E., March E.E., et al. Incidence of seizures with tricyclic and tetracyclic antidepressants. Arch Neurol 1985, 42:480-481.
29. Lee K.C., Finley P.R., Alldredge B.K. Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings. Expert Opin Drug Saf 2003, 2:233-247.
30. Isbister G.K., Bowe S.J., Dawson A., et al. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 2004, 42:277-285.
31. Suchard J.R. Fluoxetine overdose-induced seizure. West J Emerg Med 2008, 9:154-156.
32. Kirchner V., Silver L.E., Kelly C.A. Selective serotonin reuptake inhibitors and hyponatraemia: review and proposed mechanisms in the elderly. J Psychopharmacol 1998, 12:396-400.
33. Corrington K.A., Gatlin C.C., Fields K.B. A case of SSRI-induced hyponatremia. J Am Board Fam Pract 2002, 15:63-65.
34. Yilmaz Z., Ceschi A., Rauber-Lüthy C., et al. Escitalopram causes fewer seizures in human overdose than citalopram. Clin Toxicol 2010, 48:207-212.
35. Hayes B.D., Klein-Schwartz W., Clark R.F., et al. Comparison of toxicity of acute overdoses with citalopram and escitalopram. J Emerg Med 2010, 39:44-48.
36. Alldredge B.K. Seizure risk associated with psychotropic drugs: clinical and pharmacokinetic considerations. Neurology 1999, 53(Suppl 2):S68-S75.
37. Ascher J.A., Cole J.O., Colin J.N., et al. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 1995, 56:395-401.
38. Friel P.N., Logan B.K., Fligner C.L. Three fatal drug overdoses involving bupropion. J Anal Toxicol 1993, 17:436-438.
39. Davidson J. Seizures and bupropion: a review. J Clin Psychiatry 1989, 50:256-261.
40. Waring W.S., Good A.M., Bateman D.N. Lack of significant toxicity after mirtazapine overdose: a five-year review of cases admitted to a regional toxicology unit. Clin Toxicol 2007, 45:45-50.
41. LoVecchio F., Riley B., Pizon A., et al. Outcomes after isolated mirtazapine (Remeron) supratherapeutic ingestions. J Emerg Med 2008, 34:77-78.
42. Montgomery S.A. Antidepressants and seizures: emphasis on newer agents and clinical implications. Int J Clin Pract 2005, 59:1435-1440.
43. Spigset O., Hedenmalm K. Hyponatraemia and the syndrome of inappropriate antidiuretic hormone secretion (SIADH) induced by psychotropic drugs. Drug Saf 1995, 12:209-225.
44. Vanpee D., Laloyaux P., Gillet JB. Seizure and hyponatremia after overdose of trazodone. Am J Emerg Med 1999, 17:430-431.
45. Whyte I.M., Dawson A.H., Buckley N.A. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM 2003, 96:369-374.
46. Tobias J. Seizure after overdose of tramadol. South Med J 1997, 90:826-827.
47. Khalifa M., Daleau P., Turgeon J. Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes. J Pharmacol Exp Ther 1999, 291:280-284.
48. Bhugra D.K., Kaye N. Phenelizine induced grand mal seizure. Br J Clin Pract 1986, 40:173-174.
49. Albareda M., Udina C., Escartín A., et al. Seizures in a diabetic patient on monoamine oxidase inhibitors. Am J Emerg Med 1999, 17:107-108.
50. White N.C., Litovitz T., Clancy C. Suicidal antidepressant overdoses: a comparative analysis by antidepressant type. J Med Toxicol 2008, 4:238-250.
51. Vouri E., Henry J.A., Ojanperä I., et al. Death following ingestion of MDMA (ecstasy) and moclobemide. Addiction 2003, 98:365-368.
52. Singer P.P., Jones G.R. An uncommon fatality due to moclobemide. J Anal Toxicol 1997, 21:518-520.
53. Isbister G.K., Hackett L.P., Dawson A.H., et al. Moclobemide poisoning: toxicokinetics and occurrence of serotonin toxicity. Br J Clin Pharmacol 2003, 56:441-450.
54. Zaccara G., Muscas G.C., Messori A. Clinical features, pathogenesis and management of drug-induced seizures. Drug Saf 1990, 5:109-151.
55. Ellison D.W., Pentel P.R. Clinical features and consequences of seizures due to cyclic antidepressant overdose. Am J Emerg Med 1989, 7:5-10.
56. Taboulet P., Michard R., Muszynski J., et al. Cardiovascular repercussions of seizures during cyclic antidepressant poisoning. J Toxicol Clin Toxicol 1995, 33:205-211.
57. Hultén BÅ, Adams R., Askenasi R., et al. Predicting severity of tricyclic antidepressant overdose. J Toxicol Clin Toxicol 1992, 30:161-170.
58. Boehnert M.T., Lovejoy F.H. Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med 1985, 313:474-479.
59. Lavoie F.W., Gansert G.G., Weiss R.E. Value of initial ECG findings and plasma drug levels in cyclic antidepressant overdose. Ann Emerg Med 1990, 19:696-700.
60. Caravati E.M., Bossart P.J. Demographic and electrocardiographic factors associated with severe tricyclic antidepressant toxicity. J Toxicol Clin Toxicol 1991, 29:31-43.
61. Leibelt E.L., Francis P.D., Woolf A.D. ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity. Ann Emerg Med 1995, 26:195-201.
62. Buckley N.A., Dawson A.H. Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants. Lancet 1994, 343:159-162.
63. Foulke G.E., Albertson T.E. QRS interval in tricyclic antidepressant overdosage: inaccuracy as a toxicity indicator in emergency settings. Ann Emerg Med 1987, 16:160-163.
64. Bailey B., Buckley N.A., Amre D.K. A meta-analysis of prognostic indicators to predict seizures, arrhythmias, or death after tricyclic antidepressant overdose. J Toxicol Clin Toxicol 2004, 42:877-888.
65. Wedin G.P., Oderda G.M., Klein-Schwartz W. Relative toxicity of cyclic antidepressants. Ann Emerg Med 1986, 15:797-804.
66. Crome P., Newman B. The problem of tricyclic antidepressant poisoning. Postgrad Med J 1979, 55:528-532.
67. Strøm J., Madsen P.S., Nielsen N.N., et al. Acute self-poisoning with tricyclic antidepressants in 295 consecutive patients treated in an ICU. Acta Anaesthesiol Scand 1984, 28:666-670.
68. Merigian K.S., Browning R.G., Leeper K.V. Successful treatment of amoxapine-induced refractory status epilepticus with propofol (Diprivan). Acad Emerg Med 1995, 2:128-133.
69. Borys D.J., Setzer S.C., Ling L.J., et al. Acute fluoxetine overdose: a report of 234 cases. Am J Emerg Med 1992, 10:115-120.
70. Chan A.N., Gunja N., Ryan C.J. A comparison of venlafaxine and SSRIs in deliberate self-poisoning. J Med Toxicol 2010, 6:116-121.
71. Ho R., Norman R.F., van Veen M.M., et al. A 3-year review of citalopram and escitalopram ingestions. J Toxicol Clin Toxicol 2004, 42:746. [abstract].
72. Waring W.S., Gray J.A., Graham A. Predictive factors for generalized seizures after deliberate citalopram overdose. Br J Clin Pharmacol 2008, 66:861-865.
73. Spiller H.A., Ramoska E.A., Sheen S.R., et al. Bupropion overdose: a 3-year multi-center retrospective analysis. Am J Emerg Med 1994, 12:43-45.
74. Shepherd G., Velez L.I., Keyes D.C. Intentional bupropion overdoses. J Emerg Med 2004, 27:147-151.
75. Starr P., Klein-Schwartz W., Spiller H., et al. Incidence and onset of delayed seizures after overdoses of extended-release bupropion. Am J Emerg Med 2009, 27:911-915.
76. Sarko J. Antidepressants, old and new: a review of their adverse effects and toxicity in overdose. Emerg Med Clin North Am 2000, 18:637-654.
77. Gamble D.E. Trazodone overdose: four years of experience from voluntary reports. J Clin Psychiatry 1986, 47:544-546.
78. Buckley N.A., McManus P.R. Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. BMJ 2002, 325:1332-1333.
79. Heard K. The changing indications of gastrointestinal decontamination. Clin Lab Med 2006, 26:1-12.
80. Marik P.E., Varon J. The management of status epilepticus. Chest 2004, 126:582-591.
81. Pimentel L., Trommer L. Cyclic antidepressant overdoses: a review. Emerg Med Clin North Am 1994, 12:533-547.
82. Smilkstein M.J. Reviewing cyclic antidepressant cardiotoxicity: wheat and chaff. J Emerg Med 1990, 8:645-648.
83. Pentel P.R., Benowitz N.L. Tricyclic antidepressant poisoning. Management of arrhythmias. Med Toxicol 1986, 1:101-121.
84. Hoffman J.R., Votey S.R., Bayer M., et al. Effect of hypertonic sodium bicarbonate in the treatment of moderate-to-severe cyclic antidepressant overdose. Am J Emerg Med 1993, 11:336-341.
85. Sirianni A.J., Osterhoudt K.C., Calello D.P., et al. Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med 2008, 51:412-415.
86. Banahan B.F., Schelkun P.H. Tricyclic antidepressant overdose: conservative management in a community hospital with cost-saving implications. J Emerg Med 1990, 8:451-454.